Deborah Lee, NP
Nurse Practitioner · Burlington
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 9 years
- Graduated 2017
Offices
2 locations · Lahey Clinic Inc · 1,381 clinicians in this group
Hospitals listed: Lahey Hospital & Medical Center, Burlington. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Deborah Lee’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Lahey Hospital & Medical Center, BurlingtonBurlington, MAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Beth Israel Lahey Health, which runs 10 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — In-hospital fall-associated fracture rate: 0.45 (0.29 to 0.62) · 17,310 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 7.61 (5.29 to 9.94) · 2,380 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.417, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.643, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,373 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Lahey Hospital & Medical Center, Burlington
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| In-hospital fall-associated fracture rateComplications and deaths | 0.45 (0.29 to 0.62) · 17,310 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.61 (5.29 to 9.94) · 2,380 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.417 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.643 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,373 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.52 to 1.98) · 3,453 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.89 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 177.14 (147.42 to 206.86) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 197 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 198 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 436 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 1,132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.1 · 1,018 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.4 · 561 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 6,326 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.3 (0.14 to 0.45) · 16,750 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.57 (2.15 to 4.99) · 5,016 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.35 (0.21 to 2.5) · 2,426 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.3 (2.21 to 4.38) · 4,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.14 (4.39 to 11.9) · 2,289 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.29 (1.06 to 3.53) · 1,264 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0.15 to 0.98) · 13,632 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 322 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.669 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.636 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.671 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 539 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 1,296 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 12.1 · 537 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -7.7 · 1,315 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 1,041 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,091 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.3 to 7.2) · 228 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.4 to 13.6) · 228 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4 · 301 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.4 · 156 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 244 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (10.3 to 14.7) · 6,706 cases | No different | Jan 2022 – Dec 2024 |
What patients said (2,376 patients answered, 30% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 61% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$23,077
Medicare paid this office $23,077 for 256 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 99 | $14,385 | $102 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 59 | $1,871 | $23 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,091 | $84 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 51 | $750 | $14 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $660 | $60 |
See all 9 services
| Long return visit (40+ min) | 99 | $14,385 | $102 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 59 | $1,871 | $23 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,091 | $84 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 51 | $750 | $14 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $660 | $60 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 23 | $650 | $26 |
| Programming of dual lead pacemaker system | 23 | $638 | $26 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $574 | $36 |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 16 | $306 | $11 |
Who their Medicare patients are
256 Original Medicare patients in 2024. Average age 79 · 85 and older 23% · Women 43% · Also on Medicaid 9% · Health risk score 2.10. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Atrial fibrillation 75% · Heart failure 62% · Coronary heart disease 60% · Chronic kidney disease 48% · Diabetes 38% · Depression 27% · COPD 24% · Cancer 23% · Stroke 17% · Dementia 11%.
The office billed $125,537, Medicare allowed $29,344 and paid $23,077; for 450 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 256 | 450 | 79 | 2.10 | $125,537 | $23,077 |
| 2023 | 160 | 213 | 78 | 2.08 | $59,336 | $12,359 |
| 2022 | 34 | 52 | 80 | 2.52 | $15,916 | $4,195 |
| 2021 | 33 | 41 | 82 | 1.92 | $14,853 | $3,634 |
| 2020 | 27 | 32 | 78 | 1.89 | $11,120 | $2,553 |
| 2019 | 46 | 46 | 80 | 2.03 | $15,466 | $3,136 |
| 2018 | 18 | 21 | 78 | 2.26 | $8,249 | $2,308 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Long return visit (40+ min) | 68 | $8,342 | $103 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,105 | $85 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 28 | $466 | $15 |
| Programming of dual lead pacemaker system | 15 | $437 | $27 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 14 | $377 | $27 |
| Programming of single, dual, or multiple lead or leadless pacemaker system before or after surgery | 15 | $291 | $11 |
2022: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,408 | $78 |
2021: 2 services
| Long return visit (40+ min) | 13 | $1,467 | $113 |
| Return visit (30+ min) | 13 | $977 | $75 |
2020: 1 service
| Return visit (30+ min) | 13 | $716 | $55 |
2019: 2 services
| Return visit (30+ min) | 25 | $1,433 | $57 |
| Long return visit (40+ min) | 17 | $1,374 | $81 |
Drugs they prescribed that Part D paid
$740,637
Pharmacies billed $740,637 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,803 generic and 572 brand-name prescriptions · $740,637 in drug cost · 25 antibiotic prescriptions to 19 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 378 | $428,000 | $1,132 |
| Xarelto | 140 | $188,298 | $1,345 |
| Dofetilide | 200 | $51,918 | $260 |
| Metoprolol | 473 | $9,696 | $20 |
| Flecainide Acetate | 153 | $8,884 | $58 |
See all 26 drugs
| Eliquis | 378 | $428,000 | $1,132 |
| Xarelto | 140 | $188,298 | $1,345 |
| Dofetilide | 200 | $51,918 | $260 |
| Metoprolol | 473 | $9,696 | $20 |
| Flecainide Acetate | 153 | $8,884 | $58 |
| Amiodarone | 160 | $3,374 | $21 |
| Sotalol | 127 | $2,724 | $21 |
| Diltiazem 24hr Er (Cd) | 49 | $1,573 | $32 |
| Verapamil Er | 24 | $896 | $37 |
| Valsartan | 14 | $892 | $64 |
| Warfarin | 63 | $839 | $13 |
| Metoprolol | 60 | $623 | $10 |
| Furosemide | 63 | $415 | $7 |
| Atenolol | 30 | $393 | $13 |
| Clopidogrel | 18 | $298 | $17 |
| Digoxin | 17 | $281 | $17 |
| Omeprazole | 29 | $275 | $9 |
| Lisinopril | 31 | $215 | $7 |
| Amlodipine Besylate | 31 | $214 | $7 |
| Carvedilol | 28 | $196 | $7 |
| Atorvastatin | 17 | $156 | $9 |
| Spironolactone | 18 | $155 | $9 |
| Levothyroxine | 11 | $95 | $9 |
| Simvastatin | 16 | $69 | $4 |
| Tamsulosin | 15 | $58 | $4 |
| Amoxicillin | 20 | $18 | $1 |
Year by year
| 2024 | 2,375 | 776 | None | 24% | $740,637 |
| 2023 | 1,281 | 533 | None | 25% | $398,260 |
| 2022 | 567 | 133 | 0% (0) | 28% | $105,818 |
| 2021 | 474 | 123 | 0% (0) | 23% | $57,458 |
| 2020 | 501 | 109 | None | 24% | $66,849 |
| 2019 | 601 | 114 | None | 22% | $58,653 |
| 2018 | 258 | 71 | None | 23% | $15,794 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Eliquis | 186 | $198,512 | $1,067 |
| Xarelto | 70 | $86,324 | $1,233 |
| Dofetilide | 91 | $46,232 | $508 |
| Jardiance | 28 | $24,147 | $862 |
| Metoprolol | 199 | $5,901 | $30 |
| Flecainide Acetate | 68 | $4,887 | $72 |
| Sotalol | 71 | $2,208 | $31 |
| Amiodarone | 80 | $2,142 | $27 |
| Diltiazem 24hr Er (Cd) | 18 | $900 | $50 |
| Digoxin | 19 | $768 | $40 |
| Clopidogrel | 26 | $576 | $22 |
| Furosemide | 68 | $545 | $8 |
| Warfarin | 23 | $446 | $19 |
| Omeprazole | 35 | $417 | $12 |
| Torsemide | 16 | $347 | $22 |
| Metoprolol | 34 | $323 | $10 |
| Atorvastatin | 15 | $306 | $20 |
| Amlodipine Besylate | 22 | $162 | $7 |
| Spironolactone | 16 | $147 | $9 |
| Atenolol | 17 | $142 | $8 |
| Lisinopril | 14 | $118 | $8 |
| Amoxicillin | 13 | $17 | $1 |
2022: 14 drugs
| Eliquis | 68 | $43,186 | $635 |
| Jardiance | 26 | $21,559 | $829 |
| Brilinta | 28 | $12,529 | $447 |
| Rosuvastatin | 19 | $1,576 | $83 |
| Metoprolol | 54 | $1,202 | $22 |
| Clopidogrel | 45 | $766 | $17 |
| Torsemide | 15 | $565 | $38 |
| Amiodarone | 16 | $532 | $33 |
| Atorvastatin | 40 | $479 | $12 |
| Furosemide | 37 | $250 | $7 |
| Spironolactone | 13 | $107 | $8 |
| Lisinopril | 13 | $106 | $8 |
| Amoxicillin | 21 | $98 | $5 |
| Warfarin | 12 | $43 | $4 |
2021: 12 drugs
| Eliquis | 41 | $25,974 | $634 |
| Brilinta | 31 | $13,025 | $420 |
| Metoprolol | 51 | $1,112 | $22 |
| Isosorbide Mononitrate Er | 23 | $569 | $25 |
| Atorvastatin | 47 | $495 | $11 |
| Clopidogrel | 40 | $385 | $10 |
| Losartan | 28 | $336 | $12 |
| Nitroglycerin | 14 | $201 | $14 |
| Furosemide | 31 | $174 | $6 |
| Amoxicillin | 18 | $112 | $6 |
| Amlodipine Besylate | 14 | $80 | $6 |
| Lisinopril | 17 | $34 | $2 |
2020: 14 drugs
| Eliquis | 76 | $37,466 | $493 |
| Xarelto | 11 | $8,193 | $745 |
| Brilinta | 13 | $5,160 | $397 |
| Metoprolol | 85 | $2,376 | $28 |
| Prasugrel | 16 | $1,177 | $74 |
| Atorvastatin | 49 | $875 | $18 |
| Isosorbide Mononitrate Er | 13 | $475 | $37 |
| Nitroglycerin | 16 | $296 | $19 |
| Clopidogrel | 27 | $240 | $9 |
| Losartan | 17 | $137 | $8 |
| Furosemide | 13 | $116 | $9 |
| Amlodipine Besylate | 21 | $111 | $5 |
| Amoxicillin | 11 | $106 | $10 |
| Lisinopril | 16 | $80 | $5 |
2019: 16 drugs
| Eliquis | 42 | $18,998 | $452 |
| Brilinta | 48 | $17,915 | $373 |
| Amiodarone | 22 | $2,075 | $94 |
| Metoprolol | 101 | $2,028 | $20 |
| Atorvastatin | 83 | $1,194 | $14 |
| Clopidogrel | 58 | $586 | $10 |
| Nitroglycerin | 19 | $390 | $21 |
| Spironolactone | 21 | $347 | $17 |
| Carvedilol | 15 | $177 | $12 |
| Isosorbide Mononitrate Er | 11 | $150 | $14 |
| Dilt-Xr | 12 | $129 | $11 |
| Amoxicillin | 17 | $110 | $6 |
| Amlodipine Besylate | 17 | $102 | $6 |
| Furosemide | 23 | $74 | $3 |
| Warfarin | 11 | $51 | $5 |
| Lisinopril | 14 | $50 | $4 |
2018: 8 drugs
| Brilinta | 15 | $7,252 | $483 |
| Metoprolol | 36 | $640 | $18 |
| Atorvastatin | 33 | $554 | $17 |
| Nitroglycerin | 18 | $362 | $20 |
| Clopidogrel | 27 | $241 | $9 |
| Warfarin | 11 | $113 | $10 |
| Furosemide | 20 | $58 | $3 |
| Lisinopril | 11 | $42 | $4 |
Money from drug and device companies
$38 in 2025
| 2025 | 2 | 2 | None | $38 |
| 2024 | 2 | 3 | None | $89 |
| 2023 | 1 | 3 | None | $41 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Johnson & Johnson Vision Care | None | $28 | 1 payment
|
| AltaThera Pharmaceuticals | Sotalol Hydrochloride | $11 | 1 payment
|
See all 2 published payments
| AltaThera Pharmaceuticals | Meals · 2025-08-04 | Sotalol Hydrochloride | $11 |
| Johnson & Johnson Vision Care | Meals · 2025-05-28 | None | $28 |
See earlier years (2024, 2023)
2024: $89
| Medtronic | Cobalt Dr Mri Surescan | $72 | 2 payments
|
| AltaThera Pharmaceuticals | Sotalol Hydrochloride | $17 | 1 payment
|
2023: $41
| Johnson & Johnson Vision Care | Acuvue | $41 | 3 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1619486180
- Licence
- MA 2345230
- Group
- Lahey Clinic Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LA2100X (363LA2100X); Federal specialty code 363LA2200X (363LA2200X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2017-09-27
- NPI last updated
- 2026-08-13
- NPI record certified
- 2026-08-13
This is when the NPI record was last certified, not a medical board exam.